CoreFirst Bank & Trust Invests $50,000 in Corteva, Inc. (NYSE:CTVA)

CoreFirst Bank & Trust purchased a new position in Corteva, Inc. (NYSE:CTVA) during the 4th quarter, Holdings Channel.com reports. The firm purchased 874 shares of the company’s stock, valued at approximately $50,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Great Valley Advisor Group Inc. bought a new position in shares of Corteva in the third quarter worth approximately $203,000. Cerity Partners LLC boosted its stake in Corteva by 28.0% during the 3rd quarter. Cerity Partners LLC now owns 232,664 shares of the company’s stock valued at $13,678,000 after purchasing an additional 50,837 shares during the last quarter. Swedbank AB increased its holdings in shares of Corteva by 18.0% in the 3rd quarter. Swedbank AB now owns 457,877 shares of the company’s stock worth $26,919,000 after purchasing an additional 69,782 shares in the last quarter. Larson Financial Group LLC raised its stake in shares of Corteva by 62.1% in the third quarter. Larson Financial Group LLC now owns 6,957 shares of the company’s stock worth $409,000 after purchasing an additional 2,665 shares during the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Corteva by 9.0% during the third quarter. Daiwa Securities Group Inc. now owns 107,810 shares of the company’s stock valued at $6,338,000 after purchasing an additional 8,906 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares of the company’s stock, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Stock Down 0.3 %

Shares of CTVA opened at $61.91 on Wednesday. The business’s 50 day moving average is $62.50 and its 200 day moving average is $59.99. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The company has a market capitalization of $42.44 billion, a PE ratio of 47.99, a price-to-earnings-growth ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a dividend of $0.17 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. Corteva’s payout ratio is 52.71%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Citigroup boosted their target price on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Bank of America increased their price objective on shares of Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Royal Bank of Canada lifted their target price on shares of Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a research report on Friday, February 7th. Wells Fargo & Company increased their price target on Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a report on Tuesday, January 28th. Finally, UBS Group cut their price objective on Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $68.00.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.